
Heron Therapeutics HRTX
€ 0.75
-4.26%
Geschäftsbericht 2025
hinzugefügt 26.02.2026
Heron Therapeutics P/S 2011-2026 | HRTX
P/S Jährlich Heron Therapeutics
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1.28 | 2.19 | 2.57 | 1.91 | 0.00993 | 17.8 | 12 | 25.5 | 40.1 | 372 | - | - | - | - | 52.1 |
Alle Zahlen in USD-Währung
Indikatorenreichweite aus Jahresberichten
| Höchstwert | Mindestwert | Durchschnitt |
|---|---|---|
| 372 | 0.00993 | 48 |
P/S anderer Aktien in der Pharmaeinzelhändler
| Name | P/S | Preis | % 24h | Marktkapitalisierung | Land | |
|---|---|---|---|---|---|---|
|
AbCellera Biologics
ABCL
|
12.8 | $ 3.52 | -1.26 % | $ 1.05 B | ||
|
MorphoSys AG
MOR
|
1.75 | - | 2.43 % | $ 254 M | ||
|
Acorda Therapeutics
ACOR
|
0.142 | - | -24.86 % | $ 820 K | ||
|
Acasti Pharma
ACST
|
0.203 | - | 4.01 % | $ 150 M | ||
|
Advaxis
ADXS
|
144 | - | -9.65 % | $ 45.9 M | ||
|
AC Immune SA
ACIU
|
35 | $ 3.26 | 3.99 % | $ 229 M | ||
|
I-Mab
IMAB
|
94.1 | - | - | $ 866 M | ||
|
Aeglea BioTherapeutics
AGLE
|
489 | - | - | $ 1.01 B | ||
|
AgeX Therapeutics
AGE
|
0.099 | - | -10.17 % | $ 12.2 K | ||
|
Alexion Pharmaceuticals, Inc.
ALXN
|
5.53 | - | - | $ 40.3 B | ||
|
Albireo Pharma
ALBO
|
13.3 | - | -0.23 % | $ 916 M | ||
|
Aptorum Group Limited
APM
|
105 | $ 0.79 | 0.04 % | $ 4.31 M | ||
|
EyeGate Pharmaceuticals, Inc.
EYEG
|
2.39 K | - | -1.52 % | $ 24.7 M | ||
|
Arcturus Therapeutics Holdings
ARCT
|
2.65 | $ 6.39 | -3.62 % | $ 175 M | ||
|
argenx SE
ARGX
|
311 | $ 705.24 | 0.28 % | $ 25 B | ||
|
Midatech Pharma plc
MTP
|
137 | - | -18.52 % | $ 27.3 M | ||
|
Adverum Biotechnologies
ADVM
|
76.4 | - | - | $ 86.2 M | ||
|
Alterity Therapeutics Limited
ATHE
|
131 | $ 3.45 | -4.43 % | $ 8.3 B | ||
|
Ascendis Pharma A/S
ASND
|
947 | $ 229.27 | -0.76 % | $ 5 B | ||
|
Applied Genetic Technologies Corporation
AGTC
|
65.5 | - | - | $ 26.5 M | ||
|
Atea Pharmaceuticals
AVIR
|
2.11 | $ 6.07 | 0.33 % | $ 495 M | ||
|
Институт стволовых клеток человека
ISKJ
|
2.61 | - | - | - | ||
|
Athersys
ATHX
|
253 | - | 3.77 % | $ 22.4 M | ||
|
Acer Therapeutics
ACER
|
25.8 | - | 2.71 % | $ 14 M | ||
|
Aeterna Zentaris
AEZS
|
7.87 | - | 5.93 % | $ 314 M | ||
|
BioCardia
BCDA
|
18.6 | $ 1.29 | 1.57 % | $ 27.3 M | ||
|
Anika Therapeutics
ANIK
|
2.24 | $ 14.45 | 0.63 % | $ 212 M | ||
|
Aptinyx
APTX
|
204 | - | -39.0 % | $ 4.57 M | ||
|
AVEO Pharmaceuticals
AVEO
|
2.32 | - | - | $ 521 M | ||
|
Ayala Pharmaceuticals
AYLA
|
11.2 | - | - | $ 7.46 M | ||
|
Aytu BioScience
AYTU
|
0.237 | $ 2.59 | -2.08 % | $ 16.3 M | ||
|
Autolus Therapeutics plc
AUTL
|
1.37 K | $ 1.5 | -0.99 % | $ 383 M | ||
|
BioNTech SE
BNTX
|
35.7 | $ 94.98 | 4.9 % | $ 27.2 B | ||
|
CureVac N.V.
CVAC
|
281 | - | - | $ 867 M | ||
|
Burford Capital Limited
BUR
|
6.35 | $ 8.31 | 3.04 % | $ 1.34 B | ||
|
Aravive
ARAV
|
6.61 | - | -13.39 % | $ 1.45 M | ||
|
AstraZeneca PLC
AZN
|
2.17 | - | - | $ 96.9 B | ||
|
Actinium Pharmaceuticals
ATNM
|
2.57 K | $ 1.15 | 3.6 % | $ 34.6 M |